Articolul precedent |
Articolul urmator |
321 3 |
Ultima descărcare din IBN: 2023-07-11 13:20 |
SM ISO690:2012 POPA, Ana, NEGARĂ, Anatolie, ŞORIC, Gabriela, POPESCU, Ana. Particularitățile evolutive ale Covid-19 la pacienții vârstnici. In: Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, 21-23 octombrie 2020, Chişinău. Chişinău: USMF, 2020, p. 248. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” 2020 | ||||||
Congresul "Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”" Chişinău, Moldova, 21-23 octombrie 2020 | ||||||
|
||||||
Pag. 248-248 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. The new SARS-CoV-2 coronavirus affects a large number of people worldwide and the most affected are old people because of a large number of vulnerabilities. Thus, elderly and comorbid patients are at increased risk of developing severe disease and increased mortality. Objective of the study. Evaluate the evolutionary features of SARS-VOC-2 infection in elderly patients. Material and Methods. The prospective study was performed on a group of 96 patients (mean age 61.41 ± 3.42 years), with a predominance of men (men 59.3% vs. 40.7% women) hospitalized in the IMSP "Sfânta Treime" who met the clinical and laboratory-confirmed case definition with COVID-19.The data were statistically processed in the Statistics 10 program Results. From the 96 patients with COVID-19, 85 (88.54%) reported at least one comorbidity. The prevalence of specific comorbidities were: chronic coronary syndromes (40.1%), hypertension (39.7%), diabetes (16.04%), malignancy (13.04%), cerebrovascular disease (10.6%), chronic obstructive pulmonary disease (17.3%), chronic kidney disease (4.3%). Stratification of patients according to severity of relevant severe cases of disease, which accounted 58 patients (60.4%) of the study population, moderate severity - 38 (39.6%), mild forms were not established. Severe forms predominated in patients older than 65 years compared with moderate forms. Conclusion. Elderly age, male gender and the presence of comorbidities in patients with COVID-19 determine the severe course of the disease and increased mortality. |
||||||
Cuvinte-cheie COVID-19, elderly, mortality, COVID-19, vârstnic, mortalitate |
||||||
|